Try our beta test site
32 studies found for:    Open Studies | "Sweat"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Sweat"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair
Condition: Sweat Gland Diseases
Intervention: Biological: UCB Mesenchymal Stem Cells treatment
2 Not yet recruiting Evaluation of the Sensitivity of a Transdermal Device to Monitor the Sweat Alcohol Concentration
Condition: The Sweat Alcohol Concentration
Interventions: Other: oral dose of alcohol;   Device: alcotest;   Biological: blood samples;   Device: Transdermal monitor
3 Recruiting Investigating the Stability, Variability and Mechanism of Incorporation of Lipid Mediators Into Eccrine Sweat
Condition: Stability & Variability of Lipid-derived Molecules in Sweat
Interventions: Drug: Ibuprofen;   Other: Physiological induction of sweating;   Drug: Pilocarpine
4 Recruiting Proteomic Analysis of Sweat in Cutaneous Conditions
Condition: Application Site Perspiration
Intervention: Device: Skin Patch
5 Recruiting A Multi-Center Study of the CF Quantum® Sweat Test System
Condition: Cystic Fibrosis
Intervention: Device: Iontophoresis sweat test
6 Recruiting Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary Hyperhidrosis
Condition: Primary Axillary Hyperhidrosis
Interventions: Drug: WO3979;   Drug: WO3970;   Drug: WO3992;   Drug: Placebo (WO3988)
7 Recruiting A Confirmatory Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis
Condition: Hyperhidrosis
Interventions: Drug: BBI-4000 Concentration 1;   Drug: BBI-4000 Concentration 2;   Drug: BBI-4000 Concentration 3;   Drug: Vehicle (Placebo)
8 Not yet recruiting Summer Weight and Environmental Assessment Trial
Condition: Childhood Obesity
Intervention: Other: n/a - observational study
9 Not yet recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
Conditions: Adenoid Cystic Carcinoma;   Adnexal Carcinoma;   Apocrine Carcinoma;   Eccrine Porocarcinoma;   Extraocular Cutaneous Sebaceous Carcinoma;   Hidradenocarcinoma;   Keratoacanthoma;   Malignant Sweat Gland Neoplasm;   Merkel Cell Carcinoma;   Microcystic Adnexal Carcinoma;   NK-Cell Lymphoma, Unclassifiable;   Non-Melanomatous Lesion;   Paget Disease;   Papillary Adenocarcinoma;   Primary Cutaneous Mucinous Carcinoma;   Refractory Anaplastic Large Cell Lymphoma;   Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma;   Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma;   Refractory Mycosis Fungoides;   Refractory T-Cell Non-Hodgkin Lymphoma;   Sezary Syndrome;   Signet Ring Cell Carcinoma;   Skin Basal Cell Carcinoma;   Skin Basosquamous Cell Carcinoma;   Skin Squamous Cell Carcinoma;   Spiradenocarcinoma;   Squamous Cell Carcinoma of Unknown Primary Origin;   Stage III Skin Cancer;   Stage IV Skin Cancer;   Sweat Gland Carcinoma;   Trichilemmocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Biological: Talimogene Laherparepvec
10 Recruiting Miradry Treatment for Focal Axillary Hyperhidrosis
Condition: Axillary Hyperhidrosis
Intervention: Device: MiraDry ®
11 Recruiting Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis
Condition: Hyperhidrosis
Interventions: Drug: Botox (onabotulinumtoxinA);   Drug: NeuroBloc/Myobloc (rimabotulinumtoxinB);   Drug: NaCl (placebo)
12 Not yet recruiting Patients With Hidradenitis vs Patients With Psoriasis: Psychological Impact
Conditions: Psoriasis;   Hidradenitis
Intervention: Other: Observational
13 Recruiting Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
Conditions: Anemia;   Fatigue;   Fever;   Lymphadenopathy;   Lymphocytosis;   Night Sweats;   Recurrent Chronic Lymphocytic Leukemia;   Recurrent Plasma Cell Myeloma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Plasma Cell Myeloma;   Splenomegaly;   Thrombocytopenia;   Weight Loss
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Metformin Hydrochloride;   Other: Pharmacological Study;   Drug: Ritonavir
14 Not yet recruiting Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma
Conditions: Anemia;   B-Cell Prolymphocytic Leukemia;   Fatigue;   Fever;   Grade 1 Follicular Lymphoma;   Grade 2 Follicular Lymphoma;   Grade 3a Follicular Lymphoma;   Hairy Cell Leukemia;   Lymphadenopathy;   Lymphocytosis;   Lymphoplasmacytic Lymphoma;   Mantle Cell Lymphoma;   Marginal Zone Lymphoma;   Night Sweats;   Recurrent Chronic Lymphocytic Leukemia;   Recurrent Small Lymphocytic Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Small Lymphocytic Lymphoma;   Richter Syndrome;   Splenomegaly;   Thrombocytopenia;   Weight Loss
Interventions: Drug: Entospletinib;   Other: Laboratory Biomarker Analysis;   Biological: Obinutuzumab;   Other: Pharmacological Study
15 Recruiting Effects of Sildenafil on CFTR-dependent Ion Transport Activity
Condition: Cystic Fibrosis
Interventions: Drug: Sildenafil;   Drug: Placebo
16 Not yet recruiting Treatment of Hidradenitis Suppurativa With Eth 755nm Alexandrite Laser
Condition: Hidradenitis Suppurativa
Intervention: Device: Alexandrite Laser
17 Recruiting Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative Hidradenitis
Condition: Hidradenitis Suppurativa
Interventions: Drug: Apremilast;   Drug: Placebo Oral Tablet
18 Recruiting Low Dose Radiotherapy for Advanced Hidradenitis Suppurativa
Conditions: Hidradenitis Suppurativa;   Hidradenitis
Intervention: Radiation: Low dose Radiotherapy
19 Recruiting Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects
Condition: Hidradenitis Suppurativa
Intervention:
20 Recruiting Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Intervention: Drug: Adalimumab

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.